BioSpace News Archive

PreventionGenetics announced a partnership with the Little Zebra Fund, a non-profit organization dedicated to providing access to clinical genetic testing for patients in the San Francisco Bay Area.

Sangamo Therapeutics, Inc. announced the completion of its previously announced underwritten public offering of 12,650,000 shares of its common stock at a price to the public of $11.50 per share, including 1,650,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares.

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after the market close on Monday, April 29, 2019.

Addus HomeCare Corporation announced the hiring of Sean P. Gaffney as the Company’s Executive Vice President, Chief Legal Officer, effective April 29, 2019.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced podium and poster presentations of its SAKURA 3 Phase 3 open-label, long-term safety study of DaxibotulinumtoxinA for Injection (DAXI) for the treatment of glabellar (frown) lines at the 17th Aesthetics & Anti-Aging Medical World Congress (AMWC).

Use of ready-to-infuse bags eliminates steps in the complex chemotherapy preparation process, reducing exposure and mitigating inherent provider and patient safety risks

Lianluo Smart Limited is a China based professional smart service and products provider announced recently that a health sciences company invested by Lianluo Smart was successfully listed on the Nasdaq Stock Market on April 5th, 2019.

Exact Sciences Corp. announced that the company plans to release its first-quarter 2019 financial results after the close of the U.S. financial markets on Apr. 30, 2019.

Medivir AB announces that the Annual Report for 2018 now is available at the company’s website: www.medivir.com.

Partnership to focus on Alzheimer’s disease, breast cancer, diabetes, obesity